Patients with pulmonary hypertension associated with congenital heart disease make up an
increasing proportion of the total pulmonary hypertension population who bring with them …

Bronchopulmonary dysplasia (BPD) is the leading cause of chronic lung disease in infants
and the commonest complication of prematurity. Advances in respiratory and overall …

Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it
remains a life-shortening condition. There have been significant advances in imaging …

Rationale: Pulmonary arterial hypertension (PAH) is a degenerative arteriopathy that leads
to right ventricular (RV) failure. BRD4 (bromodomain-containing protein 4), a member of the …

Targeted neonatal echocardiography (TNE) involves the use of comprehensive
echocardiography to appraise cardiovascular physiology and neonatal hemodynamics to …

Pulmonary hypertension contributes to morbidity and mortality in both the term newborn
infant, referred to as persistent pulmonary hypertension of the newborn (PPHN), and the …

Hemodynamic instability and inadequate cardiac performance are common in critically ill
children. The clinical assessment of hemodynamic status is reliant upon physical …

Background Currently an echocardiographic threshold for the tricuspid regurgitation
gradient (TRG) of> 31 mmHg is recommended for screening for pulmonary hypertension …

Background Assessment of pulmonary hemodynamics is critical in the diagnosis and
management of cardiopulmonary disease of premature infants, but reliable noninvasive …

Background: Assessment of pulmonary hypertension (PH) is essential in neonates with
congenital diaphragmatic hernia (CDH). Echocardiography is widely established to quantify …